Avenue Therapeutics Receives Delist Letter from Nasdaq, Plans Hearing with Independent Panel
Avenue Therapeutics, Inc. (NASDAQ: ATXI), a pharmaceutical company based in Bay Harbor Islands, Florida, recently disclosed in a Form 8-K filing that it received a delist letter from The Nasdaq Stock Market LLC. The company was notified that it was not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq […]
More Stories
StockNews.com Initiates Coverage on TC Energy (NYSE:TRP)
StockNews.com started coverage on shares of TC Energy (NYSE:TRP – Free Report) (TSE:TRP) in a research report report published on...
China Natural Resources (NASDAQ:CHNR) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of China Natural Resources (NASDAQ:CHNR – Free Report) in a report released on Tuesday morning....
Dynatronics (NASDAQ:DYNT) Coverage Initiated at StockNews.com
StockNews.com initiated coverage on shares of Dynatronics (NASDAQ:DYNT – Free Report) in a research note published on Tuesday morning. The...
Natural Alternatives International (NASDAQ:NAII) Earns Buy Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Natural Alternatives International (NASDAQ:NAII – Free Report) in a research report report published on...
StockNews.com Initiates Coverage on Good Times Restaurants (NASDAQ:GTIM)
StockNews.com started coverage on shares of Good Times Restaurants (NASDAQ:GTIM – Free Report) in a research report report published on...
UBS Group Upgrades Hanesbrands (NYSE:HBI) to “Buy”
UBS Group upgraded shares of Hanesbrands (NYSE:HBI – Free Report) from a neutral rating to a buy rating in a...